Plasma interleukin-18 levels in hemodialysis patients: increased by dialysis process and association with interleukin-6 and tumor necrotic factor-alpha

Blood Purif. 2006;24(2):174-9. doi: 10.1159/000090411. Epub 2005 Dec 16.

Abstract

Background/aims: This study investigated changes of interleukin-18 (IL-18) levels before and after dialysis, and the possible association with other pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha).

Methods: Plasma IL-18 of healthy controls, and pre- and post-dialysis of uremic patients undergoing hemodialysis (HD) were evaluated by ELISA methodology.

Results: Plasma IL-18 levels were significantly increased in patients with maintenance HD (p <0.001) compared to its level in normal subjects. When compared to pre-dialysis levels, a significant increase in plasma IL-18 was measured at the end of HD (p = 0.032). There was a significant correlation among plasma IL-18, IL-6 and TNF-alpha levels in HD patients.

Conclusion: Plasma IL-18 concentration was significantly higher in HD patients and was significantly elevated by cellulose-based HD processes. Pre-activation of immunologically active cells may contribute to the association between pre-dialysis IL-18 and post-dialysis IL-6 and TNF-alpha levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Enzyme-Linked Immunosorbent Assay / methods
  • Female
  • Humans
  • Interleukin-18 / blood*
  • Interleukin-6 / blood*
  • Male
  • Predictive Value of Tests
  • Renal Dialysis / methods*
  • Tumor Necrosis Factor-alpha / analysis*
  • Uremia / etiology
  • Uremia / therapy

Substances

  • Interleukin-18
  • Interleukin-6
  • Tumor Necrosis Factor-alpha